News
News

The latest updates from AFAR.

AFAR in the News: UK’s Sunday Times two-part series explores halting the aging process

Sep 5
2017

AFAR in the News: UK’s Sunday Times two-part series explores halting the aging process View MoreBACK


On August 27, 2017, the UK-based national publication, The Sunday Times published the second of a two-part series of articles on innovations in aging research featuring AFAR Executive Director Stephanie Lederman, EdM, 2017 Honorary Leadership Award recipient Nathaniel David, PhD, and 1997 Paul B. Beeson Emerging Leaders Career Development Award in Aging scholar, 1994 AFAR Research Grant recipient, and AFAR Deputy Scientific Director Nir Barzilai, MD.

The article, Go hungry for years — or wait for a magic pill, features the AFAR experts sharing insights on the current and future methods of halting the human aging process, including the AFAR-managed Targeting Ageing with Metformin (TAME) trial.

The second article, accessible with a free registration, can be found here.

The first article, accessible with a free registration, can be found here.

The full Sunday Times podcast episode can be found here.

Nir Barzilai, MD is the Director of the Institute for Aging Research and the Director of the Nathan Shock Centers of Excellence in the Biology of Aging at Albert Einstein College of Medicine.

Nathaniel David, PhD is President and co-founder of Unity Biotechnology.

Stephanie Lederman, EdM is the Executive Director at AFAR.


For more information on TAME, please see our TAME FAQ page here and watch Dr. Barzilai’s recently released TEDMED talk here.





View MoreBACK TO TOP